| GlaxoSmithKline's Votrient now launched in UK for renal cell carcinoma; firm ... - The Pharma Letter |
|
|
The Pharma LetterGlaxoSmithKline announced on Friday that Votrient (pazopanib) is now available in the UK for the first-line treatment of patients with advanced renal cell ... read more |